documents: FDA-2022-D-0588-0010
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-D-0588-0010 | FDA | FDA-2022-D-0588 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice for Blood and Blood Components and Reducing the Risk of Transfusion-Transmitted Infections | Notice | 30 Day Proposed Information Collection | 2023-08-24T04:00:00Z | 2023 | 8 | 2023-08-24T04:00:00Z | 2023-09-26T03:59:59Z | 2023-09-26T01:01:03Z | 2023-18245 | 0 | 0 | 0900006485ee0a06 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref